Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Dental News Roundup February 2010 BY LAUREN UZDIENSKI, FEBRUARY 26, 2010

Dentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions." Adjusted net earnings increased 7% to $72.6 million, or $0.48 per share, missing estimates by a penny.

Henry Schein reported 4Q:09 revenues of $1.8 billion, up 8% over the year-ago period and beating estimates by $130.0 million. Dental Group sales were flat at $671.7 million, with dental consumable sales up 4% and dental equipment sales and service revenues down 7%. The company described the growth in consumables as "further evidence of positive market trends" and added that the decline in dental equipment sales has improved for two consecutive quarters. All growth rates exclude the effects of currency. Net income increased 37% to $86.4 million, or $0.94 per diluted share, beating estimates by $0.03.

nobelactive_prosthetics_new_web_tcm57-19275.jpgNobel Biocare reported 4Q:09 revenues of EUR 156.0 million ($213.6 million), flat over the year-ago period and missing estimates by EUR 5.0 million ($6.9 million.) EPS of EUR 0.21 ($0.29) missed estimates by EUR 0.05 ($0.07). The company called the market "highly challenging" and added that they are "well-poised to take advantage of a recovery, early signs of which are emerging in a number of the world's economies."

Sirona reported FQ1:10 revenue of $214.8 million, up 11% over the year-ago period and beating estimates by $13.5 million. Among segments, CAD/CAM increased by 29%; instruments were up 7%; imaging systems were up 4%; and treatment center sales were up 1%. All growth rates exclude the effects of currency. The company reported net income of $31.2 million, or $0.55 per share, compared with $5.6 million, or $0.10 per share, in FQ1:09. EPS beat estimates by $0.02.

Straumann reported 4Q:09 revenues of CHF 184.0 million ($171.7 million), down 1% over the year-ago period and missing estimates by CHF 4.0 million ($3.7 million). The company said that in 2009, low consumer confidence, rising unemployment and credit restrictions resulted in a 6% contraction of the overall dental implant market. The company does not release quarterly earnings data, though full-year net profit declined 19% to CHR 146.4 million ($136.1 million), missing estimates by CHF $5.6 million ($5.4 million.)

Product Introduction and Update
Straumann announced new branding for its digital products at the Chicago Dental Society Midwinter Meeting. With the Straumann Digital Solutions suite of products, "the company now offers state-of-the-art computer-guided surgery, intra-oral scanning and CAD/CAM prosthetics." The company also provided a preview of a new scanner that will launch later this year.

Zimmer Dental expanded their suite of Plastic Temporary Abutments for the Tapered Screw-Vent and Screw-Vent Implant Systems. The new abutments are offered in angled and straight designs, are compatible with acrylic and composite restorative materials and "allow for expedient and simplified chairside modification."

NC State researchers have developed a "smart coating" with potential applications in dental implants. According to the press release, the coating creates an amorphous layer around the implant that dissolves over time, releasing calcium phosphate to foster bone growth. The rate at which the layer dissolves can be tailored to an individual patient.

In a study of 6,000 people, scientists in Finland and the U.K. have identified several genes related to tooth development. As reported in HealthDay News, researchers found five genes associated with the time of the appearance of the first tooth and the number of teeth by age 1. One of the genes correlated to a 35% increase in the likelihood a patient will require orthodontic treatment by age 30.

Henry Schein signed a five-year agreement to distribute the Dentatus Atlas narrow body implant system in North America, Australia and New Zealand. The system is low-profile and has a small diameter, and the device can be placed with "no surgical incision and no sutures." Stanley Bergman, Chairman and CEO of Henry Schein said, “The Dentatus Atlas system stands apart and is distinctly different from other systems, with clear benefits that shorten healing time and increase patient comfort."

Nobel Biocare announced that it would expand its Preferred Partner Program to include Noritake Dental Supply. The company says the partnership "enables Nobel Biocare to offer superior end-to-end prosthetic solutions" by providing access to new materials. Additionally, the two companies will work together to develop new materials as well as collaborate on educational and training programs as well as other commercial activities. Based in Nagoya, Japan, Noritake Dental specializes in ceramics and is a subsidiary of a diversified electronics, industrial and materials manufacturer.

Email this to a colleague: